Long-term mortality after screening for colorectal cancer

New England Journal of Medicine

Volumn 369, Issue 12, 2013, Pages 1106-1114

  Shaukat, Aasma ^a,b   Mongin, Steven J ^c   Geisser, Mindy S ^c   Lederle, Frank A ^a,b   Bond, John H ^a,b   Mandel, Jack S ^d   Church, Timothy R ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d EXPONENT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANNUAL SCREENING; ARTICLE; BIBLIOGRAPHIC DATABASE; BIENNIAL SCREENING; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DEATH CERTIFICATE; FEMALE; FOLLOW UP; HEALTH CARE MANAGEMENT; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL RECORD; NATIONAL DEATH INDEX; NORMAL HUMAN; OCCULT BLOOD; POLYPECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84884183059     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1300720     Document Type: Article

References (30)

1. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
2. Kewenter J, Brevinge H, Engarås B, Haglind E, Ahrén C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing: results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73. (Pubitemid 24144518)
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-7 [Erratum, N Engl J Med 1993;329:672.]
4. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
6. Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012;61:1036-40.
7. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7. (Pubitemid 29128279)
8. Moayyedi P, Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 2006;101:380-4. (Pubitemid 43381684)
9. Gilbertsen VA, Church TR, Grewe FJ, et al. The design of a study to assess occult-blood screening for colon cancer. J Chronic Dis 1980;33:107-14. (Pubitemid 10213002)
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
11. Greenwood M. The natural duration of cancer. Rep Public Health Med Subj (Lond) 1926;33:1-26.
12. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997;16:1017-29. [Erratum, Stat Med 2007;26:3821.] (Pubitemid 27198989)
13. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
14. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345-57.
15. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial - SCORE. J Natl Cancer Inst 2011;103:1310-22. [Erratum, J Natl Cancer Inst 2011;103:1903.]
16. Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142(2):248-56, e25-e26.
17. Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am J Gastroenterol 2003;98:2299-305. (Pubitemid 37305374)
18. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
19. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
20. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004;96:770-80. (Pubitemid 38771822)
21. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72. (Pubitemid 44664644)
22. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007;96:828-31. (Pubitemid 46376632)
23. Forsberg AM, Kjellström L, Agréus L, et al. Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study. Scand J Gastroenterol 2012;47:184-90.
24. McCashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumors. Am J Gastroenterol 2001;96:882-6. (Pubitemid 32240749)
25. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 2012;21:411-6.
26. Thomas W, White CM, Mah J, Geisser MS, Church TR, Mandel JS. Longitudinal compliance with annual screening for fecal occult blood: Minnesota Colon Cancer Control Study. Am J Epidemiol 1995;142:176-82.
27. Shaukat A, Oancea C, Bond JH, Church TR, Allen JI. Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program. Clin Gastroenterol Hepatol 2009;7:1335-40.
28. German RR, Fink AK, Heron M, et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 2011;35:126-31.
29. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and longterm prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
30. Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS. Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison: the Minnesota Study. J Clin Epidemiol 1999;52:447-52. (Pubitemid 29305350)